Long-Acting Injectable Preferred for HIV Preexposure Prophylaxis
Physician's Weekly,
FRIDAY, Feb. 10, 2023 (HealthDay News) — Long-acting injectable preexposure prophylaxis (PrEP) is the preferred HIV prevention…
FRIDAY, Feb. 10, 2023 (HealthDay News) — Long-acting injectable preexposure prophylaxis (PrEP) is the preferred HIV prevention…
A new survey finds that men who would be potential users of HIV pre-exposure prophylaxis (PrEP) medication prefer long-acting…